LEXARIA BIOSCIENCE CORP. (LEXX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
30/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLEXX / S&P -28.21% / 15.20% |
LoseLEXX / S&P -68.50% / 15.00% |
LoseLEXX / S&P -49.25% / 50.40% |
| 2026-Q11/3 |
WinLEXX / S&P 26.42% / -4.33% |
LoseLEXX / S&P -30.03% / 11.30% |
LoseLEXX / S&P -20.34% / 27.70% |
| 2025-Q40/3 |
LoseLEXX / S&P -35.26% / 2.65% |
LoseLEXX / S&P 5.05% / 9.00% |
LoseLEXX / S&P 12.00% / 13.40% |
| 2025-Q33/3 |
WinLEXX / S&P 9.54% / 8.12% |
WinLEXX / S&P 52.05% / 4.61% |
WinLEXX / S&P 38.30% / 13.45% |
| 2025-Q21/3 |
LoseLEXX / S&P -49.12% / 10.94% |
WinLEXX / S&P 49.85% / 4.83% |
LoseLEXX / S&P LEXX unavailable / 10.63% |
| 2025-Q11/3 |
LoseLEXX / S&P -18.57% / -4.27% |
WinLEXX / S&P 29.95% / 4.98% |
LoseLEXX / S&P LEXX unavailable / 10.57% |
| 2024-Q41/3 |
LoseLEXX / S&P -31.15% / 2.41% |
WinLEXX / S&P 77.63% / 5.25% |
LoseLEXX / S&P LEXX unavailable / 6.15% |
| 2024-Q32/3 |
WinLEXX / S&P 9.71% / 5.89% |
WinLEXX / S&P 105.24% / 5.89% |
LoseLEXX / S&P LEXX unavailable / 6.11% |
| 2024-Q21/3 |
LoseLEXX / S&P -23.42% / 4.28% |
WinLEXX / S&P 34.05% / 5.38% |
LoseLEXX / S&P LEXX unavailable / 5.12% |
| 2024-Q12/3 |
WinLEXX / S&P 190.40% / 10.56% |
WinLEXX / S&P 23.16% / 5.71% |
LoseLEXX / S&P LEXX unavailable / 5.59% |
| 2023-Q41/3 |
WinLEXX / S&P 25.00% / 11.69% |
LoseLEXX / S&P -17.54% / 6.81% |
LoseLEXX / S&P LEXX unavailable / 7.78% |
| 2023-Q31/3 |
WinLEXX / S&P 36.99% / -3.27% |
LoseLEXX / S&P -11.43% / 7.52% |
LoseLEXX / S&P LEXX unavailable / -5.03% |
| 2023-Q21/3 |
LoseLEXX / S&P -73.16% / 8.74% |
WinLEXX / S&P 74.94% / 9.50% |
LoseLEXX / S&P LEXX unavailable / -8.57% |
| 2023-Q12/3 |
WinLEXX / S&P 10.57% / 7.50% |
WinLEXX / S&P 17.53% / 10.77% |
LoseLEXX / S&P LEXX unavailable / -15.69% |
| 2022-Q40/3 |
LoseLEXX / S&P 0.41% / 7.56% |
LoseLEXX / S&P -23.07% / 11.88% |
LoseLEXX / S&P LEXX unavailable / -17.99% |
| 2022-Q30/3 |
LoseLEXX / S&P -17.79% / -4.88% |
LoseLEXX / S&P -64.66% / 13.47% |
LoseLEXX / S&P LEXX unavailable / -1.41% |
| 2022-Q21/3 |
WinLEXX / S&P -9.70% / -16.10% |
LoseLEXX / S&P -78.77% / 13.71% |
LoseLEXX / S&P LEXX unavailable / 11.04% |
| 2022-Q10/3 |
LoseLEXX / S&P -18.11% / -4.60% |
LoseLEXX / S&P -57.50% / 15.97% |
LoseLEXX / S&P LEXX unavailable / 42.23% |
| 2021-Q40/3 |
LoseLEXX / S&P -35.62% / 11.03% |
LoseLEXX / S&P -12.40% / 15.00% |
LoseLEXX / S&P LEXX unavailable / 96.40% |
| 2021-Q31/3 |
LoseLEXX / S&P -10.57% / 0.58% |
WinLEXX / S&P 231.47% / 10.77% |
LoseLEXX / S&P LEXX unavailable / 69.42% |
| 2021-Q22/3 |
WinLEXX / S&P 24.78% / 8.55% |
WinLEXX / S&P 294.15% / 6.58% |
LoseLEXX / S&P LEXX unavailable / 51.81% |
| 2021-Q11/3 |
LoseLEXX / S&P LEXX unavailable / 6.17% |
WinLEXX / S&P 182.41% / -1.06% |
LoseLEXX / S&P LEXX unavailable / 7.39% |
| 2020-Q41/3 |
LoseLEXX / S&P LEXX unavailable / 12.15% |
WinLEXX / S&P 138.86% / -3.72% |
LoseLEXX / S&P LEXX unavailable / -33.42% |
| 2020-Q30/3 |
LoseLEXX / S&P LEXX unavailable / 8.93% |
LoseLEXX / S&P -2.05% / -2.04% |
LoseLEXX / S&P LEXX unavailable / -27.10% |
| 2020-Q21/3 |
LoseLEXX / S&P LEXX unavailable / 20.54% |
WinLEXX / S&P 8.04% / -0.46% |
LoseLEXX / S&P LEXX unavailable / -27.11% |
| 2020-Q10/3 |
LoseLEXX / S&P LEXX unavailable / -19.60% |
LoseLEXX / S&P -15.07% / 3.47% |
LoseLEXX / S&P LEXX unavailable / -14.75% |
| 2019-Q40/3 |
LoseLEXX / S&P LEXX unavailable / 9.07% |
LoseLEXX / S&P -51.09% / 5.36% |
LoseLEXX / S&P LEXX unavailable / 2.99% |
| 2019-Q30/3 |
LoseLEXX / S&P LEXX unavailable / 1.70% |
LoseLEXX / S&P -48.62% / 5.02% |
LoseLEXX / S&P LEXX unavailable / 0.21% |
| 2019-Q20/3 |
LoseLEXX / S&P LEXX unavailable / 4.30% |
LoseLEXX / S&P -44.54% / 6.64% |
LoseLEXX / S&P LEXX unavailable / 8.65% |
| 2019-Q11/3 |
LoseLEXX / S&P LEXX unavailable / 13.65% |
WinLEXX / S&P 15.04% / 8.12% |
LoseLEXX / S&P LEXX unavailable / 14.29% |
| 2018-Q41/3 |
LoseLEXX / S&P LEXX unavailable / -13.52% |
WinLEXX / S&P 445.06% / 9.05% |
LoseLEXX / S&P LEXX unavailable / 18.23% |
| 2018-Q31/3 |
LoseLEXX / S&P LEXX unavailable / 7.71% |
WinLEXX / S&P 580.85% / 10.21% |
LoseLEXX / S&P LEXX unavailable / 19.06% |
| 2018-Q21/3 |
LoseLEXX / S&P LEXX unavailable / 3.43% |
WinLEXX / S&P 485.98% / 9.03% |
LoseLEXX / S&P LEXX unavailable / 14.46% |
| 2018-Q11/3 |
LoseLEXX / S&P LEXX unavailable / -0.76% |
WinLEXX / S&P 551.31% / 7.68% |
LoseLEXX / S&P LEXX unavailable / 12.46% |
| 2017-Q41/3 |
LoseLEXX / S&P LEXX unavailable / 6.64% |
WinLEXX / S&P 101.88% / 7.03% |
LoseLEXX / S&P LEXX unavailable / 13.82% |
| 2017-Q30/3 |
LoseLEXX / S&P LEXX unavailable / 4.48% |
LoseLEXX / S&P LEXX unavailable / 5.68% |
LoseLEXX / S&P LEXX unavailable / 17.57% |
| 2017-Q20/3 |
LoseLEXX / S&P LEXX unavailable / 3.09% |
LoseLEXX / S&P LEXX unavailable / 4.83% |
LoseLEXX / S&P LEXX unavailable / 17.74% |
| 2017-Q10/3 |
LoseLEXX / S&P LEXX unavailable / 6.07% |
LoseLEXX / S&P LEXX unavailable / 3.67% |
LoseLEXX / S&P LEXX unavailable / 13.32% |
| 2016-Q40/3 |
LoseLEXX / S&P LEXX unavailable / 3.82% |
LoseLEXX / S&P LEXX unavailable / 2.09% |
LoseLEXX / S&P LEXX unavailable / 7.05% |
| 2016-Q30/3 |
LoseLEXX / S&P LEXX unavailable / 3.85% |
LoseLEXX / S&P LEXX unavailable / 0.20% |
LoseLEXX / S&P LEXX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LEXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -11.52% | 20.78% |
| Annualized return | -11.52% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LEXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -87.46% | 83.14% |
| Annualized return | -33.98% | 12.86% |
10Y · 2021-01-12 to 2026-08-27
| Metric | LEXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -82.62% | 319.30% |
| Annualized return | -16.05% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |